QS Energy, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that QS Energy, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $0 | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | $0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $50.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Apr 2, 2018 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $0 | Mar 17, 2014 |
| FY2013 | Sep 30, 2013 | $0 | Mar 17, 2014 |
| FY2013 | Jun 30, 2013 | $0 | Mar 17, 2014 |
| FY2013 | Mar 31, 2013 | $0 | Mar 17, 2014 |
| FY2013 | Dec 31, 2012 | $0 | Mar 17, 2014 |
| FY2013 | Sep 30, 2012 | $0 | Mar 17, 2014 |
| FY2013 | Jun 30, 2012 | $0 | Mar 17, 2014 |
| FY2013 | Mar 31, 2012 | $0 | Mar 17, 2014 |
| FY2013 | Dec 31, 2011 | $0 | Mar 17, 2014 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $0 | Mar 16, 2016 |
| FY2015 | Sep 30, 2015 | $0 | Mar 16, 2016 |
| FY2015 | Jun 30, 2015 | $0 | Mar 16, 2016 |
| FY2015 | Mar 31, 2015 | $0 | Mar 16, 2016 |
| FY2015 | Dec 31, 2014 | $0 | Mar 16, 2016 |
| FY2015 | Sep 30, 2014 | $180.0K | Mar 16, 2016 |
| FY2015 | Jun 30, 2014 | $60.0K | Mar 16, 2016 |
| FY2015 | Mar 31, 2014 | $0 | Mar 16, 2016 |
| FY2014 | Dec 31, 2013 | $0 | Mar 16, 2015 |
| FY2014 | Sep 30, 2013 | $0 | Mar 16, 2015 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($15.31M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.93M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.22M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($1.55M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | ($1.42M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($2.42M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($5.62M) | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | ($3.06M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($4.84M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($4.00M) | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($14.92M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.58M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($891.0K) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($1.25M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | ($1.19M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($1.82M) | Mar 31, 2022 |
| FY2011 | Dec 31, 2011 | ($8.02M) | Mar 30, 2012 |
| FY2011 | Dec 31, 2010 | ($4.72M) | Mar 30, 2012 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.61M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $191.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $203.0K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $486.0K | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $350.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $355.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $891.0K | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | $208.0K | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $243.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $279.0K | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.01M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.17M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($629.0K) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($923.0K) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | ($722.0K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($969.0K) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($2.68M) | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | ($1.48M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($1.79M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($1.63M) | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.0K | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | $0 | Jul 22, 2021 |
| FY2020 | Dec 31, 2019 | $6.0K | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | $0 | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $49.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $5.0K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $164.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $84.0K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $158.0K | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $280.0K | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $114.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $600.0K | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | $1.21M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $290.0K | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | $186.0K | Apr 2, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.93M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.86M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $5.33M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.85M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | $4.45M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $3.62M | Mar 31, 2022 |
| FY2011 | Dec 31, 2011 | $3.89M | Mar 30, 2012 |
| FY2011 | Dec 31, 2010 | $6.63M | Mar 30, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($5.88M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($5.70M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($5.24M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($4.69M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | ($4.17M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2020 | ($3.51M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | ($2.27M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | ($1.48M) | Jul 22, 2021 |
| FY2019 | Dec 31, 2017 | ($1.87M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | ($1.36M) | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($142.61M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($127.30M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($125.37M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($124.14M) | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | ($122.59M) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($121.20M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($118.79M) | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | ($113.17M) | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | ($110.11M) | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | ($105.27M) | Apr 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 31, 2022 |
| FY2014 | Dec 31, 2013 | 0 | Mar 16, 2015 |
| FY2014 | Sep 30, 2013 | 0 | Mar 16, 2015 |
| FY2014 | Jun 30, 2013 | 0 | Mar 16, 2015 |
| FY2014 | Mar 31, 2013 | 0 | Mar 16, 2015 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 30, 2023 |
| FY2014 | Dec 31, 2013 | 0 | Mar 16, 2015 |
| FY2014 | Sep 30, 2013 | 0 | Mar 16, 2015 |
| FY2014 | Jun 30, 2013 | 0 | Mar 16, 2015 |
| FY2014 | Mar 31, 2013 | 0 | Mar 16, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 17, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 543.35M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 428.42M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 392.59M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 376.07M | Apr 9, 2024 |
| FY2022 | Dec 31, 2021 | 355.30M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 323.18M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 310.11M | Jul 22, 2021 |
| FY2019 | Dec 31, 2018 | 256.12M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 234.08M | Apr 1, 2019 |
| FY2017 | Dec 31, 2016 | 199.05M | Apr 2, 2018 |